224 related articles for article (PubMed ID: 29445832)
21. Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods.
Thevis M; Thomas A; Schänzer W
Anal Bioanal Chem; 2013 Dec; 405(30):9655-67. PubMed ID: 23925796
[TBL] [Abstract][Full Text] [Related]
22. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2011 Jan; 3(1):1-14. PubMed ID: 21254451
[TBL] [Abstract][Full Text] [Related]
23. Challenges in Modern Anti-Doping Analytical Science.
Ayotte C; Miller J; Thevis M
Med Sport Sci; 2017; 62():68-76. PubMed ID: 28571012
[TBL] [Abstract][Full Text] [Related]
24. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
[TBL] [Abstract][Full Text] [Related]
25. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
Botrè F; de la Torre X; Donati F; Mazzarino M
Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
[TBL] [Abstract][Full Text] [Related]
26. Biomarker monitoring in sports doping control.
Pottgiesser T; Schumacher YO
Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
[TBL] [Abstract][Full Text] [Related]
27. Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues.
Thevis M; Geyer L; Geyer H; Guddat S; Dvorak J; Butch A; Sterk SS; Schänzer W
Drug Test Anal; 2013 May; 5(5):372-6. PubMed ID: 23559541
[TBL] [Abstract][Full Text] [Related]
28. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
[TBL] [Abstract][Full Text] [Related]
29. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
[TBL] [Abstract][Full Text] [Related]
30. Annual banned-substance review: Analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H
Drug Test Anal; 2018 Jan; 10(1):9-27. PubMed ID: 29149502
[TBL] [Abstract][Full Text] [Related]
31. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
32. The analytical chemistry of drug monitoring in athletes.
Bowers LD
Annu Rev Anal Chem (Palo Alto Calif); 2009; 2():485-507. PubMed ID: 20636072
[TBL] [Abstract][Full Text] [Related]
33. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.
Thevis M; Kuuranne T; Geyer H
Drug Test Anal; 2022 Jan; 14(1):7-30. PubMed ID: 34788500
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing.
Thevis M; Piper T; Thomas A
J Pharm Biomed Anal; 2021 Oct; 205():114312. PubMed ID: 34391136
[TBL] [Abstract][Full Text] [Related]
35. Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples.
Walpurgis K; Scheiff AB; Welz M; Müller-Reul J; Webborn N; Görgens C; Guddat S; Fußhöller G; Dib J; Thevis M
Drug Test Anal; 2019 Nov; 11(11-12):1755-1760. PubMed ID: 31670462
[TBL] [Abstract][Full Text] [Related]
36. Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.
Hullstein IR; Malerod-Fjeld H; Dehnes Y; Hemmersbach P
Drug Test Anal; 2015; 7(11-12):1025-9. PubMed ID: 26607218
[TBL] [Abstract][Full Text] [Related]
37. Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts.
Thevis M; Schänzer W; Geyer H; Thieme D; Grosse J; Rautenberg C; Flenker U; Beuck S; Thomas A; Holland R; Dvorak J
Br J Sports Med; 2013 Jan; 47(2):109-14. PubMed ID: 22554845
[TBL] [Abstract][Full Text] [Related]
38. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
Thevis M; Schänzer W
J Pharm Biomed Anal; 2014 Dec; 101():66-83. PubMed ID: 24906629
[TBL] [Abstract][Full Text] [Related]
39. Tetrahydrogestrinone analysis and designer steroids revisited.
Pereira HM; Padilha MC; Neto FR
Bioanalysis; 2009 Nov; 1(8):1475-89. PubMed ID: 21083096
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometry and illicit drug testing: analytical challenges of the anti-doping laboratories.
Botrè F
Expert Rev Proteomics; 2008 Aug; 5(4):535-9. PubMed ID: 18761462
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
